Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study.

CONCLUSIONS: We propose a tool that can be offered as an aid to physicians to enhance decision-making, clinical research, and patient counseling whenever LND is needed for PSCC. Administration of NAC and AC should be restricted to clinical and pathological N3 patients, respectively. PMID: 31053524 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31053524?dopt=Abstract

Source: Urologic Oncology - April 29, 2019 Category: Urology & Nephrology Authors: Necchi A, Lo Vullo S, Mariani L, Zhu Y, Ye DW, Ornellas AA, Watkin N, Ager M, Hakenberg OW, Heidenreich A, Raggi D, Catanzaro M, Salvioni R, Chipollini J, Azizi M, Spiess PE Tags: Urol Oncol Source Type: research